Risk assessment: Situation in northern Africa/Libyan Arab Jamahiriya and the influx of migrants* to Europe
ECDC, after conducting rapid risk assessments, has concluded that the risk of importation of infectious diseases from North Africa to the EU is considered to be low. From a public health perspective, the most urgent concern is related to the poor living conditions of the migrants, such as overcrowding and poor sanitation.
Technical guidance on the Introduction of HPV vaccines in European Union countries – an update
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
Public health guidance on varicella vaccination in the European Union
The Vaccine Preventable Diseases programme of ECDC has set up a working group to provide guidance to the European Union Member States on the potential introduction of varicella vaccination.
Expert opinion on the Introduction of HPV Vaccines in EU Countries
This guidance report lays down the scientific basis for the potential introduction of human papillomavirus (HPV) vaccines in order to help EU Member States to make policy choices
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA, 13 October 2015
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
Expert opinion on priority risk groups for influenza vaccination
This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 1st update, 3 February 2016
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Expert opinion on rotavirus vaccination in infancy: public consultation opens
The final expert opinion on rotavirus vaccination in infancy aims to provide EU/EEA Member States with information to support the decision-making process on the possible introduction of rotavirus vaccination in infancy.